Related Experiment Video
Updated: Jan 12, 2026

04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.2K
Age-related regional homogeneity changes in first-episode major depressive disorder: a REST-meta-MDD project study
Zhipeng Liu1, Hailin Wu1, Yingxiang Xu1
1Department of Psychiatry, Jiangxi Mental Hospital, Nanchang, China.
BMC Psychiatry
|November 3, 2025
Summary
Major depressive disorder (MDD) shows age-specific brain activity changes. Regional homogeneity (ReHo) patterns in MDD vary significantly across different age groups, suggesting ReHo as a potential biomarker.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Major depressive disorder (MDD) is linked to altered spontaneous brain activity.
- Regional homogeneity (ReHo), a measure of neuronal synchronization, is frequently studied in MDD.
- Age-related variations in ReHo within MDD remain largely unexplored.
Purpose of the Study:
- To investigate age-specific alterations in ReHo in first-episode MDD patients.
- To examine the interaction between age and disease on ReHo patterns.
- To assess the diagnostic potential of ReHo as a biomarker for MDD across different age groups.
Main Methods:
- Analysis of ReHo in first-episode MDD patients from the REST-meta-MDD project.
- Stratification of patients into young (16-24), adult (25-39), and middle-aged (40-54) subgroups.
- Utilized Receiver Operating Characteristic (ROC) analysis to evaluate diagnostic potential.
Main Results:
- Distinct age-specific ReHo alterations were identified in young, adult, and middle-aged MDD patients.
- Progressive age-related ReHo decline observed in specific brain regions.
- Significant disease effects and age-by-disease interactions noted in several brain areas.
- ROC analysis demonstrated robust diagnostic potential for ReHo patterns in adult and middle-aged groups.
Conclusions:
- ReHo exhibits dynamic, age-dependent characteristics in first-episode MDD.
- ReHo patterns show promise as a biomarker for MDD across the lifespan.
- Findings highlight the importance of considering age in understanding MDD pathophysiology and potential biomarkers.
Related Concept Videos
Depressive Disorders: Etiology
428
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
428
Depressive Disorders: MDD and Dysthymia
615
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
615
Depression: Overview
763
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
763
Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K
Long-term Depression
33.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.1K
Antidepressant Drugs: MAOIs and Other Agents
791
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
791

